Drug Trial Radar · NCT05119569
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
109
Actual
Start
Mar 1, 2022
Primary completion
Mar 29, 2023
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Nov 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study evaluating the effect of fenebrutinib on brain magnetic resonance imaging (MRI) in participants with RMS. The safety and pharmacokinetics of fenebrutinib will also be evaluated. Participants will be randomized to receive either fenebrutinib or placebo. This study consists of two parts: Double-blind treatment (DBT) phase and an optional Open-label extension (OLE) phase.
Conditions
- Relapsing Multiple Sclerosis
Interventions
FenebrutinibDrug
Fenebrutinib will be administered orally.
PlaceboDrug
Placebo will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- DBT Phase: New Gadolinium (Gd) - Enhancing T1 Lesion Rate Observed on Magnetic Resonance Imaging (MRI) Scans of the Brain Over 12 WeeksTime frame: MRI scans performed at Weeks 4, 8 and 12
Locations
17 sites in 6 countries. Site status is shown where the registry gives one.
Fullerton Neurology and Headache Center
Fullerton, California
Cleveland Clinic Lou Ruvo
Las Vegas, Nevada
University Clinical Centre of the Republic of Srpska
Banja Luka, Bosnia and Herzegovina
Clinical Hospital Center Rijeka - PPDS
Rijeka, Croatia
General Hospital Varazdin
Varaždin, Croatia
Klinicki bolnicki centar Zagreb
Zagreb, Croatia
Poliklinika Solmed
Zagreb, Croatia
Fakultni nemocnice u sv. Anny v Brne
Brno, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, Czechia
Vseobecna Fakultni Nemocnice V Praze - CRC - PPDS
Prague, Czechia
Nemocnice Jihlava, prispevkova organizace
Jihlava, Vyso?ina, Czechia
Clinical Center of Serbia
Belgrade, Serbia
Military Medical Academy
Belgrade, Serbia
Clinical center Kragujevac
Kragujevac, Serbia
Clinical Center Nis
Niš, Serbia
Clinical Hospital Centre Zemun
Zemun, Serbia
Univerzitna nemocnica Bratislava
Bratislava, Slovakia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.